AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Mercy Sabila

Examiner Mercy Sabila appears to be about average relative to their peer examiners. Their lifetime grant ratio is 46.2%, they average 1.97 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU Very Hard
Difficulty vs Group Very Easy
Difficulty vs TC Very Easy
Difficulty vs USPTO About Average
Average OA / Grant 1.97
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
7 years (2020-2026)
Phone
(571) 272-2562
Predicted Supervisor
Lianko G. Garyu
Supervisor Phone
(571) 270-7367
Tech Center
1600 - Biotechnology and Organic
Group
1650 - Enzymology, Microbiology, and Fermentation

Metrics

Applications Evaluated
314
Granted Applications
145
Non-Granted Applications
169
Avg OA / Grant
1.97
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1654
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 46.2% 1.97
Art Unit 25 47.8% 1.83
Group 207 41.1% 2.01
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2020 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2020; examiner may not yet have been active in the available dataset.
2020 14 11 78.6%
2021 52 36 69.2%
2022 51 34 66.7%
2023 54 27 50.0%
2024 56 24 42.9%
2025 60 13 21.7%
2026 27 0 0.0%

145 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 313 2.6% 3.8% 54.6% 5.1%
2 197 2.5% 10.2% 58.9% 6.1%
3 97 2.1% 3.1% 69.1% 5.2%
4 52 0.0% 1.9% 78.8% 0.0%
5 22 0.0% 4.5% 81.8% 0.0%
6 15 0.0% 6.7% 80.0% 0.0%
7 12 0.0% 0.0% 91.7% 0.0%
8 5 0.0% 0.0% 80.0% 0.0%
9 3 0.0% 0.0% 100.0% 0.0%
10 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
1.7%
2020
1.5%
2021
0.0%
2022
6.8%
2023
2.9%
2024
0.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.